Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cannabinoids and memory: animal studies.

Claudio Castellano1, Clelia Rossi-Arnaud, Vincenzo Cestari

  • 1Istituto di Neuroscienze del CNR, Sezione di Psicobiologia e Psicofarmacologia, Viale Marx 15, 00137 Roma, Italy. c.castellano@ipsifar.rm.cnr.it

Current Drug Targets. CNS and Neurological Disorders
|December 20, 2003
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hydroxytyrosol Mitigates Anxiety-Like Behaviors After a Traumatic Experience in Aged Mice in Parallel With Increased Neurogenesis in the Ventral and Dorsal Dentate Gyrus, and Preservation of Gut Microbiota Composition.

Journal of neurochemistry·2026
Same author

Testing the effects of presentation modality and presence of similarity percentages in the automatic image recognition system in Italy.

Frontiers in psychology·2026
Same author

Shortest-path percolation on scale-free networks.

Physical review. E·2026
Same author

The simulation of judgment in LLMs.

Proceedings of the National Academy of Sciences of the United States of America·2025
Same author

Nasal Cytology and Clinical Rhinology Support a Translational Integrative Neuroscience Perspective.

Journal of integrative neuroscience·2025
Same author

Two minds don't boost together: Target detection enhances the recognition of self-relevant, but not other-relevant, items.

Quarterly journal of experimental psychology (2006)·2025
Same journal

Partial QSAR analysis of some selected natural inhibitors of FAAH suggests a working hypothesis for the development of endocannabinoid-based drugs.

Current drug targets. CNS and neurological disorders·2005
Same journal

Therapeutic perspectives of inhibitors of endocannabinoid degradation.

Current drug targets. CNS and neurological disorders·2005
Same journal

Pharmacological properties and therapeutic possibilities for drugs acting upon endocannabinoid receptors.

Current drug targets. CNS and neurological disorders·2005
Same journal

Cannabinoids: between neuroprotection and neurotoxicity.

Current drug targets. CNS and neurological disorders·2005
Same journal

From cannabis to endocannabinoids in multiple sclerosis: a paradigm of central nervous system autoimmune diseases.

Current drug targets. CNS and neurological disorders·2005
Same journal

Endocannabinoids in neuroimmunology and stress.

Current drug targets. CNS and neurological disorders·2005
See all related articles

Cannabinoids, including Delta9-tetrahydrocannabinol (Delta9-THC), impair memory in animals by acting on CB1 receptors. The endogenous cannabinoid anandamide also affects memory consolidation and influences different mouse strains.

Area of Science:

  • Neuroscience
  • Pharmacology

Background:

  • Two cannabinoid receptor subtypes, CB1 and CB2, have been identified.
  • CB1 receptors are concentrated in brain areas crucial for memory, such as the hippocampus and amygdala.
  • Delta9-tetrahydrocannabinol (Delta9-THC) is a well-known cannabinoid compound.

Purpose of the Study:

  • To review studies on the effects of cannabinoid receptor agonists and antagonists on memory in laboratory animals.
  • To explore the role of CB1 receptors in mediating cannabinoid-induced memory impairments.
  • To examine the effects of the endogenous cannabinoid anandamide on memory processes.

Main Methods:

  • Review of existing literature on cannabinoid effects on animal memory models.
  • Analysis of studies using various behavioral tasks (e.g., radial maze, Morris water maze).

Related Experiment Videos

  • Investigation of the antagonism of Delta9-THC effects by CB1 receptor antagonists like SR 141716A.
  • Examination of anandamide's impact on memory consolidation in different mouse strains and its interaction with other neurotransmitter systems.

    • Main Results:

    • Delta9-THC has been shown to impair memory in rodents and non-human primates across various experimental paradigms.
    • The CB1 receptor antagonist SR 141716A antagonized the memory-impairing effects of Delta9-THC, confirming CB1 receptor involvement.
    • Anandamide, an endogenous cannabinoid ligand, impairs memory consolidation in mice.
    • Anandamide's effects on memory are genotype-dependent in inbred mouse strains and may involve opioid and dopaminergic systems.

    Conclusions:

    • Cannabinoid receptor agonists, particularly acting via CB1 receptors, significantly influence memory processes in laboratory animals.
    • The endogenous cannabinoid system, including anandamide, plays a role in memory modulation.
    • Further research is warranted to elucidate the complex interactions between cannabinoid systems and other neurotransmitter pathways in memory.